Literature DB >> 22130498

Janus kinase 3: the controller and the controlled.

Wei Wu1, Xiao-Hong Sun.   

Abstract

Janus kinase (JAK)-signal transducer and activators of transcription (STAT) signaling pathways play crucial roles in lymphopoiesis. In particular, JAK3 has unique functions in the lymphoid system such that JAK3 ablation results in phenotypes resembling severe combined immunodeficiency syndrome. This review focuses on the biochemistry, immunological functions, and clinical significance of JAK3. Compared with other members of the JAK family, the biochemical properties of JAK3 are relatively less well characterized and thus largely inferred from studies of JAK2. Furthermore, new findings concerning the cross-talks between Notch and JAK signaling pathways through ubiquitin-mediated protein degradation are discussed in more detail.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130498      PMCID: PMC3284110          DOI: 10.1093/abbs/gmr105

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  98 in total

1.  Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways.

Authors:  H Luo; P Rose; D Barber; W P Hanratty; S Lee; T M Roberts; A D D'Andrea; C R Dearolf
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  Genomic sequence, organization, and chromosomal localization of human JAK3.

Authors:  M C Riedy; A S Dutra; T B Blake; W Modi; B K Lal; J Davis; A Bosse; J J O'Shea; J A Johnston
Journal:  Genomics       Date:  1996-10-01       Impact factor: 5.736

3.  Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.

Authors:  S Y Park; K Saijo; T Takahashi; M Osawa; H Arase; N Hirayama; K Miyake; H Nakauchi; T Shirasawa; T Saito
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

4.  The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals.

Authors:  M Chen; A Cheng; Y Q Chen; A Hymel; E P Hanson; L Kimmel; Y Minami; T Taniguchi; P S Changelian; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

5.  Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop.

Authors:  J Feng; B A Witthuhn; T Matsuda; F Kohlhuber; I M Kerr; J N Ihle
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

6.  Peripheral expression of Jak3 is required to maintain T lymphocyte function.

Authors:  D C Thomis; L J Berg
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

7.  Crucial role of Jak3 in negative selection of self-reactive T cells.

Authors:  K Saijo; S Y Park; Y Ishida; H Arase; T Saito
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

8.  Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells.

Authors:  C B Gurniak; L J Berg
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

9.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

Authors:  P Macchi; A Villa; S Giliani; M G Sacco; A Frattini; F Porta; A G Ugazio; J A Johnston; F Candotti; J J O'Shea
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

10.  Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

Authors:  S M Russell; N Tayebi; H Nakajima; M C Riedy; J L Roberts; M J Aman; T S Migone; M Noguchi; M L Markert; R H Buckley; J J O'Shea; W J Leonard
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

View more
  11 in total

Review 1.  Inflammatory pathways of importance for management of inflammatory bowel disease.

Authors:  Jannie Pedersen; Mehmet Coskun; Christoffer Soendergaard; Mohammad Salem; Ole Haagen Nielsen
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

2.  The brain parenchyma has a type I interferon response that can limit virus spread.

Authors:  Eugene Drokhlyansky; Didem Göz Aytürk; Timothy K Soh; Ryan Chrenek; Elaine O'Loughlin; Charlotte Madore; Oleg Butovsky; Constance L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-15       Impact factor: 11.205

3.  Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.

Authors:  Yung-Chun Wang; Xiao-Bing Cui; Ya-Hui Chuang; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-04       Impact factor: 8.311

4.  Phosphatidic Acid Increases Epidermal Growth Factor Receptor Expression by Stabilizing mRNA Decay and by Inhibiting Lysosomal and Proteasomal Degradation of the Internalized Receptor.

Authors:  Nathaniel Hatton; Erin Lintz; Madhu Mahankali; Karen M Henkels; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2015-06-29       Impact factor: 4.272

5.  Understanding the structural features of JAK2 inhibitors: a combined 3D-QSAR, DFT and molecular dynamics study.

Authors:  Sathya Babu; Santhosh Kumar Nagarajan; Thirumurthy Madhavan
Journal:  Mol Divers       Date:  2019-01-07       Impact factor: 2.943

6.  Janus Kinase 3 Deficiency Promotes Vascular Reendothelialization-Brief Report.

Authors:  Yung-Chun Wang; Dunpeng Cai; Xiao-Bing Cui; Ya-Hui Chuang; William P Fay; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-04-29       Impact factor: 10.514

7.  Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.

Authors:  Mercedes García-Bermúdez; Raquel López-Mejías; Fernanda Genre; Santos Castañeda; Alfonso Corrales; Javier Llorca; Carlos González-Juanatey; Begoña Ubilla; José A Miranda-Filloy; Trinitario Pina; Carmen Gómez-Vaquero; Luis Rodríguez-Rodríguez; Benjamín Fernández-Gutiérrez; Alejandro Balsa; Dora Pascual-Salcedo; Francisco J López-Longo; Patricia Carreira; Ricardo Blanco; Javier Martín; Miguel A González-Gay
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

8.  WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells.

Authors:  Hui Zhang; Yun-Kai Zhang; Yi-Jun Wang; Rishil J Kathawala; Atish Patel; Hua Zhu; Kamlesh Sodani; Tanaji T Talele; Suresh V Ambudkar; Zhe-Sheng Chen; Li-Wu Fu
Journal:  Cancer Sci       Date:  2014-08-21       Impact factor: 6.716

9.  Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles.

Authors:  Jung Seok Kim; Min Woo Kim; Seong Jae Kang; Hwa Yeon Jeong; Sang Il Park; Yeon Kyung Lee; Hong Sung Kim; Keun Sik Kim; Yong Serk Park
Journal:  Int J Nanomedicine       Date:  2018-08-27

10.  JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.

Authors:  Gigliola Di Matteo; Maria Chiriaco; Alessia Scarselli; Cristina Cifaldi; Susanna Livadiotti; Silvia Di Cesare; Valentina Ferradini; Alessandro Aiuti; Paolo Rossi; Andrea Finocchi; Caterina Cancrini
Journal:  Mol Genet Genomic Med       Date:  2018-07-21       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.